Search results
Feb 3, 2021 · The Moderna COVID-19 vaccine has been authorised for use in Singapore in individuals aged 18 years and above. The first shipment arrived in Singapore on 17 February 2021. Details of the Moderna COVID-19 vaccine. For individuals aged 18 years and above; Two doses required, administered 28 days apart; High vaccine efficacy of 94%
- Rolling Data Submission For Speedier Evaluation
- Vaccine Safety and Efficacy
- Active Monitoring and Continuous Review of Data
4 The Moderna COVID-19 vaccine is the second COVID-19 vaccine to be granted interim authorisation under PSAR. This regulatory pathway facilitates access to critical novel vaccines, medicines and medical devices during a pandemic such as the current COVID-19 pandemic. 5 Using PSAR, HSA can start evaluating new vaccines, medicines and medical devices...
7 HSA’s review of the available clinical data found that the vaccine demonstrated a high vaccine efficacy of 94%. This means that there is a 94% reduction of symptomatic COVID-19 disease in a vaccinated group of people as compared to a similarly sized group of unvaccinated people. This vaccine efficacy was based on a Phase III clinical trial conduc...
10 As a condition for the interim authorisation under PSAR, Moderna is required to monitor the longer-term efficacy of the vaccine to determine the duration of protection against COVID-19. This will augment the available data which shows that the vaccine continues to be effective at two months following the completion of the vaccination regime, wit...
2. What is the Moderna COVID-19 vaccine? The Moderna COVID-19 vaccine protects against COVID-19. The vaccine contains messenger RNA (mRNA) which helps your immune system to produce protection. The vaccine reduces the risks of infection and severe disease from COVID-19, and has good protection against the current virus variants.
- 145KB
- 2
The Moderna/Spikevax vaccines have been authorised by the Health Sciences Authority (HSA) for use in Singapore. The vaccines are available for persons aged 6 months and above.
Pfizer-BioNTech, Moderna and Novavax have successfully obtained full registration with the Health Sciences Authority (HSA) for their vaccines. Under the National Vaccination Programme (NVP), vaccination is free for all eligible Singaporean Citizens, Permanent Resident, Long Term Pass Holders and certain Short Term Pass holders.
Which vaccines are approved for use in Singapore? Which of these vaccines are included in the national vaccination programme? A: Pfizer-BioNTech/Comirnaty, Moderna/Spikevax and Novavax/Nuvaxovid are vaccines that are authorised by the Health Sciences Authority (HSA) for use in Singapore.
Sep 14, 2022 · SINGAPORE - The Health Sciences Authority (HSA) on Wednesday granted interim authorisation for the use of Moderna's Spikevax bivalent Covid-19 vaccine, which targets both the original...
.png?sfvrsn=b282a727_2&q=moderna%20singapore&ck=26083B14BDB2C738C49F91CCAB94157C&idpp=rc&idpview=singleimage&form=rc2idp "moderna singapore1")
.jpg?sfvrsn=aceaece_0&q=moderna%20singapore&ck=60BE3E5D92A5E42586E1C2BB79469CB7&idpp=rc&idpview=singleimage&form=rc2idp "moderna singapore5")
